ATEC · XBRL financial data

Alphatec Holdings financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ATEC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cost of revenue	42	85	118	172	187	232
Gross profit	103	158	233	310	424	532
Selling, general and administrative	129	229	300	374	450	499
Total operating expenses	161	286	380	484	560	614
Operating income (loss)	(59)	(128)	(147)	(173)	(136)	(82)
Interest expense	12	7	6	17	25	46
Other income (expense)	—	(2)	0	3	(1)	2
Income tax expense (benefit)	0	0	0	(0)	0	(0)
Net income (loss)	(79)	(144)	(152)	(187)	(162)	(143)
Earnings per share, basic USD per share	(1.18)	(1.49)	(1.47)	(1.54)	(1.13)	(0.96)
Earnings per share, diluted USD per share	(1.18)	(1.49)	(1.47)	(1.54)	(1.13)	(0.96)
Weighted average shares, basic millions of shares	67	96	103	121	143	150
Weighted average shares, diluted millions of shares	67	96	103	121	143	150

Fiscal years (ATEC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	108	187	85	221	139	161
Accounts receivable	24	42	60	73	83	97
Inventory	46	92	102	137	175	169
Prepaid and other current assets	5	10	9	21	20	23
Total current assets	184	331	256	451	417	451
Property and equipment, net	37	87	102	150	156	135
Right-of-use asset	1	25	28	26	35	31
Goodwill	14	40	40	73	71	75
Total assets	261	572	513	805	776	791
Accounts payable	18	26	35	49	53	41
Accrued liabilities	35	—	—	—	—	—
Current portion of long-term debt	4	0	15	2	2	65
Total current liabilities	58	101	139	158	153	219
Long-term debt	38	326	350	511	575	501
Lease liability, non-current	0	24	27	24	27	24
Accumulated deficit	(638)	(782)	(934)	(1,119)	(1,281)	(1,424)
Total stockholders' equity	130	79	(37)	78	(14)	12
Total liabilities and equity	261	572	513	805	776	791
Common shares outstanding (cover page) millions of shares	95	100	111	138	144	151

Fiscal years (ATEC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(79)	(144)	(152)	(187)	(162)	(143)
Stock-based compensation	18	36	41	81	73	74
Depreciation and amortization	11	27	41	56	78	77
Net cash from operating activities	(46)	(73)	(75)	(78)	(45)	45
Purchases of property and equipment	23	69	49	81	83	42
Net cash from investing activities	(24)	(158)	(58)	(142)	(93)	(53)
Proceeds from issuing common stock	3	132	—	213	0	0
Share repurchases	—	25	—	—	—	—
Net cash from financing activities	131	312	31	357	56	30
Net change in cash	61	79	(103)	136	(82)	22

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Alphatec Holdings	80	221	19*	155.1M	—	Q3 FY26 10-QSep 30, 2026
Tandem Diabetes Care	63	255	(35)*	69.6M	13.2 quarters	Q2 FY26 10-QJun 30, 2026
Artivion	77	126	(1.3)*	48.8M	61.1 quarters	Q2 FY26 10-QJun 30, 2026
CONMED	48	336	49*	29.8M	—	Q3 FY26 10-QSep 30, 2026
AtriCure	187	154	not reported	50.9M	—	Q3 FY26 10-QSep 30, 2026
NovoCure	97	193	23	116.9M	—	Q3 FY26 10-QSep 30, 2026
Lemaitre Vascular	27	not reported	16*	22.9M	—	Q2 FY26 10-QJun 30, 2026
Establishment Labs Holdings	71	68	(17)*	29.8M	4.3 quarters	Q2 FY26 10-QJun 30, 2026
Ufp Technologies	9	174	16*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.